by Vita Maziveyi | Sep 23, 2024 | Science, Weekly News
Why we think it’s important: The study discussed in this blog is important because it helps clarify the limited effectiveness of cannabis-based medicine in managing pain associated with traumatic brachial plexus injuries. Imagine dealing with intense, persistent...
by Stephanie Wood Miller | Sep 16, 2024 | Weekly Cannabis News, Weekly News
An update on DEA rescheduling marijuana. New research on marijuana use among seniors and youth. New research on menstrual pain and cannabis use and Covid-19 outcomes. Marijuana rescheduling won’t happen before the election...
by Vita Maziveyi | Sep 9, 2024 | Weekly Cannabis News, Weekly News
Why we think it’s important The article discussed in this blog highlights the therapeutic potential of minor phytocannabinoids, which could offer new avenues for medical treatments beyond the well-known effects of THC and CBD. Understanding these compounds could lead...
by Stephanie Wood Miller | Sep 3, 2024 | Weekly Cannabis News, Weekly News
Issues with unregulated Delta 8-THC continue. Two promising studies out of Germany this week regarding anti-aging, mental capacity, and endometriosis. A new study suggests reduced risk of obesity among marijuana users. The Associated Press outlines the risks of Delta...
by Stephanie Wood Miller | Aug 12, 2024 | Weekly Cannabis News, Weekly News
The controversy continues about athletes and the use of cannabis following the Paris Olympics. This week we celebrate Sha’Carri Richardson’s gold medal and examine both the science and the politics around marijuana and athletic performance. Sha’Carri Richardson gets...
by Stephanie Wood Miller | Jul 29, 2024 | Weekly Cannabis News, Weekly News
DEA comment period ends. GOP lawmakers express doubt about rescheduling marijuana but are out of sync with a majority of Americans. Promising research on cancer treatment and among drug abusers. Watch our Journal Club and read two studies on the reduction of craving...
